Expanding local access to clinical trials improves options by reducing barriers and bringing research opportunities closer to ...

The ensuing crossover disturbs randomization and may lead to biased longer-term analysis, compromising the utility of clinical data. This has been especially apparent in recent adjuvant and prevention ...

Clinical trials are losing participants. Patient-first design and decentralized models can help fix the dropout problem.

Seaport Therapeutics Announces Positive Proof of Concept Topline Results from Ongoing Phase 1 Trial of GlyphAgo in Healthy ...